alexa Predictors Of Time To Poor Treatment Outcomes In Patients With Multi-drug Resistant Tuberculosis In Northwest Ethiopia
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th International Congress on Bacteriology and Infectious Diseases
May 25-26, 2017 Chicago, USA

Kefyalew Addis Alene, Kerri Viney, Emma S McBryde, Adino Tesfahun and Archie Clements
Australian National University, Australia
Burnet Institute, Australia
University of Melbourne, Australia
James Cook University, Australia
University of Gondar, Ethiopia
Posters & Accepted Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597-C1-029
Background: Multidrug-resistant tuberculosis (MDR-TB) is an emerging public health problem. The aim of this study was to assess MDR-TB treatment outcomes and determine predictors of time to poor treatment outcomes. Methods: We used a retrospective cohort study design. The study participants were all MDR-TB patients who had complete records and who were enrolled at Gondar University Hospital since the establishment of the MDR-TB program in 2010. A Cox-proportional hazard model was used to identify the predictors of time to poor treatment outcomes, which were defined as death or treatment failure. Results: Of the 242 patients who had complete records, 131 (54%) were cured, 23 (9%) completed treatment, 31 (13%) died, 4 (2%) experienced treatment failure, 27 (11%) were lost to follow up, 6 (2%) transferred out, and 20 (8%) were still on treatment at the time of analysis. The overall cumulative probability survival of the patients at the end of treatment (which was 24 months in duration) was 80% (95%CI: 70%, 87%). The proportion of patients with poor treatment outcomes increased over time from 6% per person-year (PY) during 2010–2012 to 12% per PY during 2013–2015. The independent predictors of time to poor treatment outcome were: Being anemic [AHR=4.20; 95%CI: 1.11, 15.90] and being a farmer [AHR=2.24; 95% CI: 1.03, 4.88]. Conclusion: Overall, in northwest Ethiopia, the MDR-TB treatment success rate was high. However, poor treatment outcomes have gradually increased since 2012. It would be beneficial to provide nutritional supplementation, especially for farmers during the course of MDR-TB treatment. Key Message: High MDR-TB treatment success can be achieved in resource-limited settings; poor treatment outcomes have gradually increased; and nutritional supplementation and early diagnosis and treatment of MDR-TB would be beneficial to improve poor treatment outcomes.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version